Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,502Revenue (TTM) $M84.6Net Margin (%)-76.1Altman Z-Score20.5
Enterprise Value $M4,429EPS (TTM) $-1.5Operating Margin %-70.3Piotroski F-Score4
P/E(ttm)--Beneish M-Score-0.4Pre-tax Margin (%)-76.1Higher ROA y-yY
Price/Book99.810-y EBITDA Growth Rate %--Quick Ratio6.2Cash flow > EarningsN
Price/Sales51.85-y EBITDA Growth Rate %--Current Ratio6.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-34.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-110.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M45.4ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ANAC

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ANACGeorge Soros 2016-03-31 Buy 0.01%$53.45 - $114.27
($74.7)
$ 99.2433%New holding4,200
ANACJoel Greenblatt 2015-09-30 Sold Out -0.01%$77.84 - $152.25
($130.63)
$ 99.24-24%Sold Out0
ANACJoel Greenblatt 2015-06-30 Buy 0.01%$52.69 - $79.09
($65.44)
$ 99.2452%New holding13,741
ANACFirst Eagle Investment 2013-03-31 Sold Out -0.0017%$3.15 - $6.52
($4.35)
$ 99.242181%Sold Out0
ANACFirst Eagle Investment 2012-12-31 Buy $4.6 - $6.81
($5.55)
$ 99.241688%New holding92,390
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ANAC is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ANAC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Leonard Keith RDirector 2016-05-23Sell9,000$99.7-0.46view
Hove Anders DDirector 2016-05-16Sell353,881$99.59-0.35view
Sullivan Ryan TEVP and General Counsel 2016-04-29Sell3,125$66.3349.62view
Hove Anders DDirector 2016-04-08Sell229,301$71.139.58view
BERNS PAUL LPresident and CEO 2016-03-22Sell37,500$60.3164.55view
IPPOLITO VINCENT PEVP & Chief Commercial Officer 2016-03-02Sell9,000$63.8655.4view
IPPOLITO VINCENT PEVP & Chief Commercial Officer 2016-01-19Sell20,000$95.414.01view
Zane LeeSVP and Chief Medical Officer 2016-01-15Sell1,466$89.5710.8view
IPPOLITO VINCENT PEVP & Chief Commercial Officer 2016-01-04Sell855$112.28-11.61view
Sullivan Ryan TSr. VP and General Counsel 2016-01-04Sell733$111.78-11.22view

Quarterly/Annual Reports about ANAC:

    News about ANAC:

    Articles On GuruFocus.com
    Royce Smaller-Companies Growth Fund Annual Letter Mar 19 2016 
    Royce Funds Comments on Anacor Pharmaceuticals Oct 12 2015 
    Staying Diversified in the Pursuit of Sustainable Growth - Royce Funds Commentary Oct 12 2015 
    Royce Smaller-Companies Growth Fund Shareholder Letter Sep 20 2015 
    Panic-Proofing the Small Investor Aug 26 2015 
    Anacor Pharmaceuticals’ Q4 Was A Solid One For Investors Mar 16 2015 
    Paulson Bets Again On Mallinckrodt Aug 07 2014 
    3 Great Dividend Stocks at All-Time Highs Aug 19 2013 
    Weekly CFO Buys Highlight Aug 19 2013 
    Senior Vice President and CFO of Anacor Pharmaceuticals Inc. Geoffrey Parker Bought 43,046 Shares Jun 20 2013 

    More From Other Websites
    Buy Pfizer, Chevron, Newell Brands and Enjoy the Profits May 25 2016
    Why Pfizer, Chevron and Newell Brands Could be Great For Your Portfolio May 25 2016
    XBI’s and IHI’s Mid-Caps Soared, Overturning 2 Weeks of Losses May 25 2016
    XBI Was a Top Performer in the Biotechnology Sector May 24 2016
    Pfizer Bets Big on Eczema With Anacor Acquisition May 23 2016
    [$$] Charting the Market May 20 2016
    SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Anacor... May 20 2016
    INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Into Whether the Sale of Anacor... May 20 2016
    ANACOR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Anacor... May 20 2016
    The Zacks Analyst Blog Highlights: Medivation, Anacor, Aduro, Trevena and Tetraphase May 20 2016
    Four reasons for investors to buy biotechnology stocks now May 20 2016
    SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Anacor... May 19 2016
    Biotech Stock Roundup: Pfizer to Buy Anacor for $5.2B, Pipeline Setbacks for Aduro, Trevena May 19 2016
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Regarding the Fairness of the Sale... May 19 2016
    Anacor Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP... May 18 2016
    ANACOR PHARMACEUTICALS, INC. Financials May 18 2016
    Ryan & Maniskas, LLP Announces Investigation of Anacor Pharmaceuticals, Inc. May 18 2016
    Why Is Anacor Trading through the Deal Terms? May 18 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)